EyePoint, Inc. (EYPT)
12.33
+0.56
(+4.76%)
USD |
NASDAQ |
Jun 10, 16:00
12.09
-0.24
(-1.95%)
After-Hours: 20:00
EyePoint SG&A Expense (Quarterly) : 15.25M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 15.25M |
| December 31, 2025 | 11.38M |
| September 30, 2025 | 14.52M |
| June 30, 2025 | 11.90M |
| March 31, 2025 | 13.91M |
| December 31, 2024 | 12.64M |
| September 30, 2024 | 12.99M |
| June 30, 2024 | 12.80M |
| March 31, 2024 | 14.11M |
| December 31, 2023 | 11.43M |
| September 30, 2023 | 11.04M |
| June 30, 2023 | 14.34M |
| March 31, 2023 | 14.98M |
| December 31, 2022 | 14.41M |
| September 30, 2022 | 15.23M |
| June 30, 2022 | 15.44M |
| March 31, 2022 | 15.24M |
| December 31, 2021 | 17.03M |
| September 30, 2021 | 13.43M |
| June 30, 2021 | 11.84M |
| March 31, 2021 | 10.77M |
| December 31, 2020 | 11.59M |
| September 30, 2020 | 11.06M |
| June 30, 2020 | 10.88M |
| March 31, 2020 | 12.48M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.55M |
| September 30, 2019 | 12.14M |
| June 30, 2019 | 12.10M |
| March 31, 2019 | 11.92M |
| December 31, 2018 | 9.268M |
| September 30, 2018 | 7.807M |
| June 30, 2018 | 5.732M |
| March 31, 2018 | 2.281M |
| June 30, 2017 | 2.624M |
| March 31, 2017 | 2.426M |
| December 31, 2016 | 2.90M |
| September 30, 2016 | 3.285M |
| June 30, 2016 | 2.656M |
| March 31, 2016 | 2.346M |
| December 31, 2015 | 2.043M |
| September 30, 2015 | 1.968M |
| June 30, 2015 | 2.411M |
| March 31, 2015 | 2.041M |
| December 31, 2014 | 1.87M |
| September 30, 2014 | 1.734M |
| June 30, 2014 | 2.00M |
| March 31, 2014 | 1.946M |
| December 31, 2013 | 1.711M |
| September 30, 2013 | 1.811M |
| June 30, 2013 | 2.153M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 36.58M |
| Rapport Therapeutics, Inc. | 11.50M |
| Merck & Co., Inc. | 2.70B |
| Bristol Myers Squibb Co. | 1.617B |
| Praxis Precision Medicines, Inc. | 27.87M |